Development of novel therapy method using a recombinant oncolytic measles virus

被引：0
|
作者：
Kai, Chieko [1 ]
Fujiyuki, Tomoko [1 ]
Moritoh, Kanako [1 ]
Nagamura, Fumitaka [2 ]
Furukawa, Yoichi [3 ]
Takahashi, Shunji [4 ]
Yoneda, Misako [5 ]
机构：
[1] Univ Tokyo, Inst Ind Sci, Dept Mech, Biofunct Sys, Tokyo, Japan
[2] Univ Tokyo, Inst Med Sci, Ctr Transl Res, Tokyo, Japan
[3] Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Tokyo, Japan
[4] JFCR, Canc Inst Hosp, Dept Med Oncol, Tokyo, Japan
[5] Univ Tokyo, Inst Ind Sci, Virol Med, Tokyo, Japan
来源：
CANCER SCIENCE | 2022年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SS1-6
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Recombinant measles viruses encoding suicide genes for oncolytic therapy
    Springfeld, C
    von Messling, V
    Frenzke, M
    Cattaneo, R
    [J]. MOLECULAR THERAPY, 2004, 9 : S224 - S224
  • [12] Engineering and combining oncolytic measles virus for cancer therapy
    Leber, Mathias F.
    Neault, Serge
    Jirovec, Elise
    Barkley, Russell
    Said, Aida
    Bell, John C.
    Ungerechts, Guy
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2020, 56 : 39 - 48
  • [13] Oncolytic measles virus strains as novel anticancer agents
    Msaouel, Pavlos
    Opyrchal, Mateusz
    Musibay, Evidio Domingo
    Galanis, Evanthia
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2013, 13 (04) : 483 - 502
  • [14] Using Cystine Knot Proteins as a Novel Approach to Retarget Oncolytic Measles Virus
    Lal, Sangeet
    Raffel, Corey
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2017, 7 : 57 - 66
  • [15] Development of new therapy for canine mammary cancer with recombinant measles virus
    Shoji, Koichiro
    Yoneda, Misako
    Fujiyuki, Tomoko
    Amagai, Yosuke
    Tanaka, Akane
    Matsuda, Akira
    Ogihara, Kikumi
    Naya, Yuko
    Ikeda, Fusako
    Matsuda, Hiroshi
    Sato, Hiroki
    Kai, Chieko
    [J]. MOLECULAR THERAPY-ONCOLYTICS, 2016, 3 : 15022
  • [16] Potential applicable range of oncolytic virotherapy with a recombinant measles virus in dogs
    Fujiyuki, Tomoko
    Shoji, Koichiro
    Iizuka, Keigo
    Horikirizono, Yu
    Sato, Hiroki
    Asano, Kazushi
    Yoneda, Misako
    Kai, Chieko
    [J]. CANCER SCIENCE, 2018, 109 : 1037 - 1037
  • [17] Development of oncolytic measles virus, rMV-SLAMblind
    Kai, C.
    Fujiyuki, T.
    Shoji, K.
    Sato, H.
    Yoneda, M.
    [J]. HUMAN GENE THERAPY, 2017, 28 (12) : A25 - A25
  • [18] Development of recombinant vesicular stomatitis virus for use as an oncolytic vector in cancer therapy
    Heiber, Joshua
    Hyun, Jinhee
    Obuchi, Masatsugu
    Barber, Glen N.
    [J]. CYTOKINE, 2009, 48 (1-2) : 47 - 47
  • [19] Development of a Regulatable Oncolytic Herpes Simplex Virus Type 1 Recombinant Virus for Tumor Therapy
    Yao, Feng
    Murakami, Nao
    Bleiziffer, Oliver
    Zhang, Pengwei
    Akhrameyeva, Natali V.
    Xu, Ximing
    Brans, Richard
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (16) : 8163 - 8171
  • [20] Immune checkpoint blockade enhances oncolytic Measles virus therapy
    Engeland, C. E.
    Veinalde, R.
    Grossardt, C.
    Shevchenko, I.
    Umansky, V.
    Nettelbeck, D. M.
    Jaeger, D.
    von Kalle, C.
    Ungerechts, G.
    [J]. HUMAN GENE THERAPY, 2014, 25 (11) : A47 - A47
12345